ARCHIVE

• FPMAJ Opposes More Frequent NHI Price Revisions
  October 17, 2005

• 1,636 Organ Transplants in Japan Since 1995
  October 17, 2005

• Safety Div. to Monitor Drug Information Supply by Companies
  October 17, 2005

• JPMA to Revise Its Promotion Code
  October 17, 2005

• REGULATORY NEWS IN BRIEF
  October 17, 2005

• Approval of NPO-operated IRBs Recommended by Expert Group
  October 10, 2005

• NHO Introduced 100% Piecework System for Contract Clinical Trial Fees
  October 10, 2005

• Japan Should More Actively Participate in Global Clinical Trials: Mr Mori of PMDA
  October 10, 2005

• PMDA to Comprehensively Revise Consultation System
  October 10, 2005

• R&D NEWS IN BRIEF
  October 10, 2005

• JSH Calls for Reduction of Daily Salt Intake to Less Than 6 g
  October 10, 2005

• Social Security Benefits Rose 0.8% to \84.3 Trillion in FY2003
  October 10, 2005

• Dainippon Sumitomo, Aska Pharm., Mediceo Paltac Inaugurated on Oct. 1
  October 10, 2005

• SELF-MEDICATION NEWS IN BRIEF
  October 10, 2005

• Dainippon Sumitomo Starts Marketing under New System
  October 10, 2005

• Daiichi Sankyo Sets Out Forecasting Sales of \894.5 Bil. in FY2005
  October 10, 2005

• BUSINESS NEWS IN BRIEF
  October 10, 2005

• NEW PRODUCTS
  October 10, 2005

• Brand Names of GE Drugs Must Be Based on Their Generic Names: Korosho
  October 10, 2005

• Sawai: Survey Indicates Sharp Increase in GE Drug Awareness
  October 10, 2005

ページ

• « 先頭
• ‹ Prev
• …
• 442
• 443
• 444
• 445
• 446
• 447
• 448
• 449
• 450
• …
• Next ›
• 最終 »